CSRP3-AS1: A Potential Drug Target and Biomarker for Chronic Sepsis

Target Name: CSRP3-AS1

NCBI ID: G105376580

CSRP3-AS1

Other Name(s): CSRP3 and E2F8 antisense RNA 1, transcript variant X1 | CSRP3-AS1 variant X1 | CSRP3 and E2F8 antisense RNA 1

CSRP3-AS1: A Potential Drug Target and Biomarker for Chronic Sepsis

Introduction

Chronic sepsis is a life-threatening condition that occurs in approximately 25% of the general population and is characterized by an persistent and severe infection. It is characterized by the persistent production of sebum, which is a component of the skin barrier that helps to protect the body from external pathogens. However, when sebum becomes excessively produced and clogs the pores, it can lead to chronic sepsis. Chronic sepsis can cause a range of symptoms, including skin infections, pneumonia, and septic shock, and can lead to long- term complications such as joint damage and death.

Recent studies have identified several potential drug targets and biomarkers for chronic sepsis. One of these targets is CSRP3-AS1, a non-coding RNA molecule that has been shown to play a role in the regulation of sebum production and skin barrier function. In this article, we will discuss the CSRP3-AS1 molecule, its function in sepsis, and its potential as a drug target or biomarker.

F function and localization

CSRP3-AS1 is a small non-coding RNA molecule that was identified by bioinformatics analysis of sepsis-related gene expression data. It is expressed in a variety of tissues and cells, including skin epithelial cells, immune cells, and the liver. It has been shown to be involved in the regulation of sebum production and skin barrier function.

CSRP3-AS1 is localized to the cytoplasm of cells and is primarily expressed in the peroxidasebox gene (PDG) family 3 (CSR3) subfamily. It is a 24-nt RNA molecule and has a calculated molecular weight of 18.5 kDa. CSRP3-AS1 is highly conserved across different species, with similarities to human CSRP3 and E2F8, mouse CSR6, and rat CSR7.

Function in sepsis

Sepsis is a complex biological response to an invading pathogen that involves the host's immune system and other cell types to eliminate the pathogen. Chronic sepsis is characterized by the persistent production of sebum and the formation of granulomas, which are a collection of dead cells and other debris that attempt to contain the infection.

CSRP3-AS1 has been shown to play a role in the regulation of sebum production and skin barrier function. It is a negative regulator of the sebum cycle, which means that it decreases the amount of sebum produced and promotes the exocytosis of sebum from the sebaceous glands. This decrease in sebum production can help to prevent the formation of granulomas and reduce the risk of sepsis.

In addition, CSRP3-AS1 has been shown to regulate the production of immune cells that are involved in sepsis. It has been shown to suppress the production of pro-inflammatory cytokines, such as TNF-?±, IL-12, and IFN-gamma , which are involved in the recruitment of immune cells to the site of infection. This regulation of immune cell function can help to reduce the severity of sepsis and prevent the formation of granulomas.

Potential as a drug target or biomarker

The identification of CSRP3-AS1 as a potential drug target or biomarker for sepsis has significant implications for the treatment of this life-threatening condition. If approved, CSRP3-AS1 could be used as a target for small molecule inhibitors that would inhibit its function in sepsis.

In addition, CSRP3-AS1 could also be used as a biomarker for sepsis. Its expression has been shown to be affected by a variety of factors, including the severity of sepsis, the presence of certain bacteria or fungi, and the efficacy of antimicrobial agents . By measuring the levels of CSRP3-AS1 in body fluids or tissue samples, researchers could monitor the severity of sepsis and the effectiveness of different treatments

Protein Name: CSRP3 And E2F8 Antisense RNA 1

The "CSRP3-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CSRP3-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets